These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19883850)

  • 1. Application of a risk scoring system to predict surgical adverse events in the management of epithelial ovarian cancers.
    Li AJ
    Gynecol Oncol; 2009 Dec; 115(3):323-4. PubMed ID: 19883850
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen.
    Bristow RE
    Gynecol Oncol; 2009 Jan; 112(1):1-3. PubMed ID: 19100914
    [No Abstract]   [Full Text] [Related]  

  • 3. Should we centralise care for the patient suspected of having ovarian malignancy?
    Geomini PM; Kruitwagen RF; Bremer GL; Massuger L; Mol BW
    Gynecol Oncol; 2011 Jul; 122(1):95-9. PubMed ID: 21439618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic importance of rupture of stage I ovarian cancer].
    Mizuno M; Kikkawa F; Mizutani S
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():587-91. PubMed ID: 15535313
    [No Abstract]   [Full Text] [Related]  

  • 5. Commenting on "future directions in the surgical management of ovarian cancer" by Berman 90:s35-39.
    Eisenkop SM
    Gynecol Oncol; 2004 Jul; 94(1):235-6; author reply 238-40. PubMed ID: 15262151
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quality control of the surgical management of advanced ovarian carcinoma].
    Pomel C; Lecuru F; Rouzier R; Dauplat J; Ferron G
    J Gynecol Obstet Biol Reprod (Paris); 2012 Feb; 41(1):3-5. PubMed ID: 22192233
    [No Abstract]   [Full Text] [Related]  

  • 7. Not qualified--a patient's perspective.
    Pniauskas S
    Gynecol Oncol; 2006 Mar; 100(3):630. PubMed ID: 16413600
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary surgery by a gynecological oncologist improves the prognosis in patients with ovarian carcinoma].
    van der Zee AG; Engelen MJ; Schaapveld M; Karim-Kos HE; de Vries EG; Willemse PH; Otter R
    Ned Tijdschr Geneeskd; 2009 Jan; 153(1-2):15-9. PubMed ID: 19198207
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical audit in gynecological cancer surgery: development of a risk scoring system to predict adverse events.
    Kondalsamy-Chennakesavan S; Bouman C; De Jong S; Sanday K; Nicklin J; Land R; Obermair A
    Gynecol Oncol; 2009 Dec; 115(3):329-33. PubMed ID: 19758690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes.
    Bristow RE; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Armstrong DK
    Gynecol Oncol; 2009 Dec; 115(3):334-8. PubMed ID: 19766295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chairperson's introduction: Surgical skills, especially in the upper abdomen, remain pivotal in the treatment of advanced ovarian cancer.
    Vergote I
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S86-7. PubMed ID: 21944034
    [No Abstract]   [Full Text] [Related]  

  • 12. What do operative risk classification systems actually tell us about operative risk?
    BJOG; 2019 Jul; 126(8):1077. PubMed ID: 31033137
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical management of giant ovarian tumors.
    Einenkel J; Handzel R
    J Obstet Gynaecol Res; 2008 Feb; 34(1):125; author reply 127. PubMed ID: 18226145
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of conservative treatment of epithelial ovarian tumor.
    Morice P; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P
    Gynecol Oncol; 2009 Mar; 112(3):673-4; author reply 674. PubMed ID: 18986689
    [No Abstract]   [Full Text] [Related]  

  • 15. Small bowel volvulus caused by re-implantation and growth of remnant tissue from a previously excised ovarian mucinous cystadenoma.
    Huang CY; Huang SC
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):346-8. PubMed ID: 17627695
    [No Abstract]   [Full Text] [Related]  

  • 16. Advanced cytoreductive surgery: American perspective.
    Zivanovic O; Aldini A; Carlson JW; Chi DS
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S3-9. PubMed ID: 19573703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancer.
    Naik R; Spirtos N; Pomel C; Bristow R; Chi D; Vergote I; Donovan J
    Int J Gynecol Cancer; 2013 May; 23(4):588-91. PubMed ID: 23611959
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: A statement for extensive primary cytoreductive surgery in advanced ovarian cancer.
    Nevin J; Luesley D
    BJOG; 2008 Nov; 115(12):1586; author reply 1586-7. PubMed ID: 19036008
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized study of aggressive surgery for advanced ovarian cancer.
    Querleu D; Rafii A; Colombo PE; Ferron G; Rouanet P; Martinez A
    Int J Gynecol Cancer; 2013 Sep; 23(7):1170. PubMed ID: 23970153
    [No Abstract]   [Full Text] [Related]  

  • 20. Advanced cytoreductive surgery in gynecologic oncology.
    Bristow RE
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S1-2. PubMed ID: 19573698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.